Founded in 2004, Prognosys Medical Systems designs and manufactures digital medical imaging equipment under the ProRad™ brand. Headquartered in Bengaluru, the company has grown from an importer and distributor of digital X-ray systems into a full-stack engineering and manufacturing organisation – developing radiology and fluoroscopy solutions for hospitals, clinics, field deployments, and veterinary globally.
In 2022, Molbio Diagnostics — a pioneer in point-of-care molecular diagnostics – became the majority stakeholder in Prognosys, combining radiology and molecular diagnostics to enable end-to-end disease screening at the point of care.
Prognosys holds ISO 13485, ISO 9001, and IS 7620 certifications, with products approved by the US FDA and CE. Its customers include Apollo Hospitals, AIIMS, Narayana Health, Max Healthcare, and the WHO.
Key Personnel
Mr. Krishna Prasad Vajapeyam
Founder & President, Prognosys Medical Systems
An engineer by training, with a degree from Bangalore University and a Master’s from the United States – Krishna Prasad Vajapeyam has spent over three decades building technology businesses. He founded Prognosys in 2004, growing it from a small Bengaluru-based distribution venture into a nationally recognised medical imaging company with a global footprint.
Mr. Sriram Natarajan
Chairman & CEO, Molbio Diagnostics
Sriram Natarajan holds M.Sc. and M.Phil. degrees and brings over 34 years of experience in developing, manufacturing, and marketing diagnostic devices for global markets. He founded the Tulip Group in 1989, scaling it into India’s largest IVD reagent company with a significant global presence, before exiting in 2017. He subsequently founded Molbio Diagnostics with a focused mission to bring modern, high-quality diagnostic technologies to the point of care – across both private and public health systems.
Dr. Chandrasekhar Nair
Director & CTO, Molbio Diagnostics
Dr. Chandrasekhar Nair holds Bachelor’s and Master’s degrees in Chemical Engineering from BITS Pilani and a PhD in Bio-MEMS from VIT. He brings deep expertise in bioprocess modelling, scale-up, and commercialisation of bio and chemical technologies. Over the past decade, his work has focused on developing rapid, portable, and cost-effective diagnostic solutions that extend the capabilities of a modern laboratory to point-of-care settings – strengthening access to quality diagnostics worldwide.
Journey
Prognosys was Estd in 2004. Prognosys worked with Govt of India to establish a nation-wide digital health network.
2004
Importer and distributor Canon Digital X-ray Systems (DR) enters India in association with Prognosys
2007
First local Integration of DR systems
2010
Pioneered the digitisation of x-rays (DR) across multiple state-wide networks
2012
Somerset Indus invests into Prognosys to design and manufacture a range of indigenous digital x-ray products
2015
• Prognosys products get CE & FDA Approval
• Prognosys starts exports to SE Asia & Africa
2018
• Prognosys and Molbio collaborate for end-to-end TB solutions
• WHO awards order for End-to-End Mobile E- Clinic for TB Screening Solution
2022
• Molbio Diagnostics acquires majority stake in Prognosys Medical Systems
2023
Global Footprint
